Antiger Therapeutics Inc.

Biotechnology company · Saint Louis, Missouri, United States

Antiger Therapeutics Inc. is a biotechnology company headquartered in Saint Louis, Missouri, United States. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $869,457 in total, most recently in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Antiger Therapeutics at a glance

Typebiotechnology company

HeadquartersSaint Louis, Missouri, United States

Employees (self-reported, 2025)3

What does Antiger Therapeutics do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $869,457 in total (2023 to 2025). NIH funding came from the National Institute of Allergy and Infectious Diseases.

Frequently asked questions about Antiger Therapeutics

Where is Antiger Therapeutics headquartered?

Antiger Therapeutics Inc. is headquartered in Saint Louis, Missouri, United States.

What does Antiger Therapeutics do?

Antiger Therapeutics Inc. is a biotechnology company.

Similar companies

MediBeacon Inc.St. Louis, Missouri, United States
C2N Diagnostics, LLCSt. Louis, Missouri, United States
Pulse Therapeutics, Inc.St. Louis, Missouri, United States
Panome Bio Inc.St. Louis, Missouri, United States
Cardialen, Inc.St. Louis, Missouri, United States
Gateway Biotechnology, Inc.St. Louis, Missouri, United States
Confluence Life Sciences, Inc.St. Louis, Missouri, United States
BacterioScan, Inc.St. Louis, Missouri, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences